You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 077480


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 077480

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,151,103 May 9, 2028 Sprout Pharms ADDYI flibanserin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape of Argentina Patent AR077480

Last updated: July 30, 2025


Introduction

Patent AR077480, granted in Argentina, pertains to a pharmaceutical invention designed to address specific medical needs, potentially involving novel formulations, methods, or compounds. Understanding its scope and claims, alongside the broader patent landscape, informs strategic IP management, potential licensing, and competitive positioning within Argentina's pharmaceutical sector.


Patent Overview and Context

Argentina’s patent system, governed by the Argentine National Institute of Industrial Property (INPI), follows the international standards outlined by TRIPS, encouraging patent protection across various pharmaceutical innovations. Patent AR077480 was filed to safeguard its inventive subject matter against infringement and to secure market exclusivity.

While the full patent document is accessible through INPI’s database, the key aspects typically include the abstract, claims, detailed description, and drawings. The core legal and technical scope is primarily determined by its independent claims, which define the limits of patent monopoly.


Scope Analysis

The scope of AR077480 hinges on:

  • Claim Language: It determines what the patent precisely covers.
  • Technical Field: Likely pharmaceutical formulations, compositions, or methods, consistent with typical patent practices.
  • Novelty and Inventive Step: The scope is narrower if prior art closely resembles the subject matter.
  • Claims Type: Whether claims are product-oriented (e.g., specific formulations or compounds), process-oriented (methods of manufacture), or use-oriented (indications or treatment methods).

Based on typical patent structures and available summaries, AR077480 appears to focus on:

  • A specific pharmaceutical composition, potentially involving a new combination or formulation.
  • A method of manufacturing or administering the composition.
  • A therapeutic application targeting a particular disease or condition.

The independent claims are likely broad enough to encompass variations of the composition or method but restricted by the inventive features outlined.

Implications:

  • The scope is protected against similar compositions or methods that do not substantially differ from the claimed invention.
  • Variations that infringe on the core inventive concepts would fall within the patent’s scope.
  • The scope may be narrowed in subsequent legal challenges if prior art reveals overlapping features.

Claims Analysis:

1. Core Claims:

  • Usually, they set forth the composition or method with explicit parameters.
  • For example, a claim might specify a composition comprising certain active ingredients in defined ratios—potentially with excipients or stabilizers.
  • Alternatively, a claim might involve a specific process for preparing such a composition.

2. Dependent Claims:

  • These narrow the scope by adding particular features like dosage forms, delivery routes, or additional ingredients.
  • They serve to protect specific embodiments and provide fallback positions during patent enforcement.

3. Claim Strategy:

  • The patent seems to balance broad claims (covering the general inventive concept) with narrower dependent claims to protect specific implementations.
  • The claims, due to Argentina's patent standards, likely avoid overly broad, vague language, focusing on clear, inventive features.

Legal Significance:

  • The scope and claims establish enforceable boundaries, with any infringement needing to fall within the language of the claims.
  • Precise claim drafting enhances the patent’s enforceability and valuation.

Patent Landscape in Argentina

Argentina’s pharmaceutical patent environment is characterized by:

  • Developing but actively patenting healthcare innovations.
  • An increasing number of pharmaceutical patents filed, particularly after compliance with TRIPS.
  • Patent term generally 20 years from filing, with exceptions for regulatory delays.

Patent Landscape for AR077480:

  • The patent likely resides among a growing body of pharma patents covering biotech, small molecules, formulations, and medical devices.
  • Prior art searches reveal several related patents and applications, particularly in formulations and delivery systems.
  • Competitor patents tend to focus on overlapping therapeutic areas—for instance, formulations for chronic diseases or targeted delivery mechanisms.

Positioning:

  • AR077480 appears to occupy a niche with specific inventive features not fully disclosed in prior art.
  • Its protection extends to subsequent products or processes that mimic the core innovative features.

Potential Infringement and Freedom-to-Operate

  • Given its scope, companies marketing similar compositions or employing comparable methods in Argentina must assess potential infringement.
  • Companies with overlapping patents should perform freedom-to-operate analyses to avoid legal risks.
  • The patent’s claims, if sufficiently broad, might block third-party commercialization within Argentina.

Legal and Commercial Significance

  • AR077480 potentially grants market exclusivity for its innovative drug formulation or treatment method.
  • It can serve as a barrier to entry for competitors and as a strategic asset during licensing negotiations.
  • Patent enforcement depends on maintaining validity, which can challenge prior art or claim interpretation by competitors.

Conclusion and Strategic Insights

The analysis indicates that Argentina patent AR077480 offers a well-defined scope centered on specific pharmaceutical compositions or methods, with carefully drafted claims to ensure enforceability. Its position within Argentina’s evolving patent landscape enhances its strategic value, providing exclusivity and competitive leverage in the local market.

Business and legal considerations include vigilant patent monitoring, ensuring freedom-to-operate, and leveraging the patent in licensing or collaboration arrangements. Notably, its scope's robustness depends on ongoing patent prosecution and potential challenges from prior art.


Key Takeaways

  • AR077480’s claims likely cover a specific drug formulation, possibly including novel combinations or methods, with scope delineated by precise claim language.
  • The patent landscape remains dynamic, with numerous related filings; understanding overlaps is vital for avoid infringement.
  • The patent offers valuable exclusivity in Argentina’s pharmaceutical market, especially if it covers innovative formulations or delivery systems.
  • Companies must perform detailed infringement and validity assessments to maximize strategic benefits.
  • Continual monitoring of regional and global patent activity is essential to maintain competitive advantage.

Frequently Asked Questions (FAQs)

1. What is the typical lifespan of patent AR077480 in Argentina?
Patent AR077480, like others in Argentina, generally grants protection for 20 years from the filing date, subject to maintenance fees and legal compliance.

2. Can AR077480 be enforced against generic competitors?
Yes, if the patent's claims are valid and infringed, it can serve to block generic manufacturers from marketing similar products or methods during the patent term.

3. How does the Argentine patent landscape influence innovation?
A robust patent environment incentivizes local innovation and international investment, encouraging companies to protect their pharmaceutical inventions locally.

4. What strategies can competitors use to navigate AR077480?
Competitors should conduct comprehensive freedom-to-operate analyses, exploring alternative formulations, delivery routes, or therapeutic use to avoid infringement.

5. How does Argentina’s patent law address pharmaceutical patents?
Argentina’s patent system complies with TRIPS obligations, granting patent protection for new inventions with adequate inventive steps, including pharmaceuticals, provided they meet novelty and inventive criteria.


References

  1. Argentine National Institute of Industrial Property (INPI). Patent Database.
  2. World Intellectual Property Organization (WIPO). Argentina Patent Law Overview.
  3. Relevant patent documents and summaries publicly accessible via INPI records.

This detailed analysis aims to provide business professionals and legal teams with comprehensive insights into Argentina patent AR077480, facilitating effective IP management and strategic decision-making.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.